Renaissance Technologies LLC 13D and 13G filings for Corcept Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 2:12 pm Sale | 2025-12-31 | 13G | CORCEPT THERAPEUTICS INCORPORA CORT | Renaissance Technologies LLC | 5,758,528 5.470% | -967,343 (-14.38%) | Filing |
| 2024-02-13 10:04 am Sale | 2023-12-29 | 13G | CORCEPT THERAPEUTICS INCORPORA CORT | Renaissance Technologies LLC | 6,725,871 6.520% | -563,000 (-7.72%) | Filing |
| 2023-02-13 09:54 am Sale | 2022-12-30 | 13G | CORCEPT THERAPEUTICS INCORPORA CORT | Renaissance Technologies LLC | 7,288,871 6.770% | -734,745 (-9.16%) | Filing |
| 2022-02-11 11:38 am Sale | 2021-12-31 | 13G | CORCEPT THERAPEUTICS INCORPORA CORT | Renaissance Technologies LLC | 8,023,616 6.950% | -1,317,880 (-14.11%) | Filing |